Krystal Biotech, Inc. (KRYS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

The Zacks Rank, which is a unique, proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, that makes building a winning portfolio easier.

BUD's fourth-quarter 2024 results are likely to show the impacts of challenging macroeconomic conditions and higher expenses.

FSLR's Q4 results are expected to reflect robust top-line performance, driven by capacity expansion and strong demand, amid ...

In the closing of the recent trading day, JPMorgan Chase & Co. (JPM) stood at $279.25, denoting a -0.25% change from the preceding trading day.

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Freshworks Inc. (FRSH Quick Quote FRSH - Free Report) : This software development company has seen the Zacks Consensus Estimate ...

Zacks Investment Research (Zacks) last year reportedly suffered another data breach that exposed sensitive information ...

CELH's Q4 results are likely to reflect the impacts of internal and external challenges, while growth endeavors should offer ...

The Zacks Rank is a unique, proprietary stock-rating model that utilizes earnings estimate revisions to help investors build a winning portfolio. There are four main factors behind the Zacks Rank ...